ClinicalTrials.gg
Sign In
CompletedNCT00286039Updated Jul 13, 2021

Plasma Citrulline Level in Relation to Absorptive Surface

An interventional study of Blood sampling in Intestinal Failure, sponsored by University Hospital, Ghent. Completed at 1 site in Belgium. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2021-07-13.

Sponsored by University Hospital, Ghent · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
Up to 18 Years
Sex
All
01

Study summary

Correlation between determination of citrulline in plasma or dried blood

Reference ranges for healthy children and babies

Longitudinal follow-up of citrulline in preterm babies

02

Conditions studied

  • Intestinal Failure

Browse trials for

03

In context

Intestinal Failure

64 studies on the registry are indexed under Intestinal Failure; 17 are open to participants now.

This study's enrollment of 200 is above the median of 38 across 42 interventional studies indexed under Intestinal Failure.

Browse Intestinal Failure studies →

Lead sponsor

University Hospital, Ghent is the lead sponsor of 689 studies on the registry; 160 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Browse University Hospital, Ghent studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 0-18 years
  • preterm babies up to 1.500g
  • preterm babies over 1.500g

Exclusion criteria

Exclusion Criteria:

  • gastro-intestinal problems (except for the preterm babies)
  • congenital metabolic disorders
  • dysfunction of the liver or kidneys
  • congenital defects
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (actual)

Interventions

  • ProcedureBlood sampling

    Blood sampling is used.

06

What researchers measure

Primary outcomes

  1. Correlation between determination of citrulline in plasma or dried blood

    Time frame: Untill end of study

  2. Reference ranges for healthy children and babies

    Time frame: Until end of study

  3. Longitudinal follow-up of citrulline in preterm babies

    Time frame: Untill end of study

07

Study locations

1 site
  • University Hospital Ghent
    Ghent, 9000, Belgium
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2005, a primary completion of Sep 2010 and a completion of Sep 2010. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 1, 2006
First posted
Feb 2, 2006
Start
Aug 2005
Primary completionActual
Sep 2010
CompletionActual
Sep 2010
Last update
Jul 13, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00286039
Lead sponsor
University Hospital, Ghent
Responsible party
Sponsor
First posted
Feb 2, 2006
Start date
Aug 2005
Primary completion
Sep 2010
Completion
Sep 2010
Last update
Jul 13, 2021

Study contacts

Eddy Robberecht, MD, PhD
principal investigator · University Hospital, Ghent

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Intestinal Failure →

Other studies from this sponsor

University Hospital, Ghent →

Start the discussion